These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22365732)

  • 1. Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.
    Finkenstedt A; Widschwendter A; Brasse-Lagnel CG; Theurl I; Hubalek M; Dieplinger H; Tselepis C; Ward DG; Vogel W; Zoller H
    Blood Cells Mol Dis; 2012 Apr; 48(4):233-7. PubMed ID: 22365732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I.
    Shalev H; Perez-Avraham G; Kapelushnik J; Levi I; Rabinovich A; Swinkels DW; Brasse-Lagnel C; Tamary H
    Eur J Haematol; 2013 Jan; 90(1):31-6. PubMed ID: 23095116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients?
    Malyszko J; Malyszko JS; Levin-Iaina N; Koc-Zorawska E; Kozminski P; Mysliwiec M
    Int Urol Nephrol; 2012 Dec; 44(6):1805-11. PubMed ID: 22130959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
    Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
    Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
    Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
    Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
    Tamary H; Shalev H; Perez-Avraham G; Zoldan M; Levi I; Swinkels DW; Tanno T; Miller JL
    Blood; 2008 Dec; 112(13):5241-4. PubMed ID: 18824595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
    Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
    Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hemojuvelin and hepcidin levels in chronic kidney disease.
    Rumjon A; Sarafidis P; Brincat S; Musto R; Malyszko J; Bansal SS; Macdougall IC
    Am J Nephrol; 2012; 35(3):295-304. PubMed ID: 22398782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.
    Robach P; Recalcati S; Girelli D; Campostrini N; Kempf T; Wollert KC; Corbella M; Santambrogio P; Perbellini L; Brasse-Lagnel C; Christensen B; Moutereau S; Lundby C; Cairo G
    Eur J Haematol; 2013 Jul; 91(1):74-84. PubMed ID: 23582009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
    Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
    Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.
    Lin L; Goldberg YP; Ganz T
    Blood; 2005 Oct; 106(8):2884-9. PubMed ID: 15998830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.
    Tanno T; Rabel A; Lee YT; Yau YY; Leitman SF; Miller JL
    Transfusion; 2010 Jul; 50(7):1532-5. PubMed ID: 20210929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemojuvelin: a new link between obesity and iron homeostasis.
    Luciani N; Brasse-Lagnel C; Poli M; Anty R; Lesueur C; Cormont M; Laquerriere A; Folope V; LeMarchand-Brustel Y; Gugenheim J; Gual P; Tran A; Bekri S
    Obesity (Silver Spring); 2011 Aug; 19(8):1545-51. PubMed ID: 21311510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
    Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
    Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
    Krijt J; Fujikura Y; Sefc L; Vokurka M; Hlobenová T; Necas E
    Physiol Res; 2010; 59(1):53-59. PubMed ID: 19249912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.
    Casanovas G; Swinkels DW; Altamura S; Schwarz K; Laarakkers CM; Gross HJ; Wiesneth M; Heimpel H; Muckenthaler MU
    J Mol Med (Berl); 2011 Aug; 89(8):811-6. PubMed ID: 21475976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
    Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR
    J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.